Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The inositol trisphosphate (IP₃)-induced calcium release pathway is a fundamental intracellular signaling mechanism that regulates numerous physiological processes by controlling the release of calcium ions (Ca²⁺) from internal stores, primarily the endoplasmic reticulum (ER). This pathway is initiated when IP₃, a second messenger produced in response to various extracellular signals, binds to its receptor—the inositol 1,4,5-trisphosphate receptor (IP₃R)—on the ER membrane. The binding event opens the channel and allows Ca²⁺ stored at high concentrations within the ER to flow into the cytoplasm. Elevated cytosolic Ca²⁺ triggers downstream signaling events affecting metabolism, secretion, gene transcription, muscle contraction, fertilization responses, neuronal activity and more. Regulation of this pathway can be achieved through modulation of IP3 production or IP3R activity.
Modulation of IP3 production/degradation or IP3R activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol Trisphosphate-Induced Calcium Release Pathway.